↓ Skip to main content

IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Overview of attention for article published in Blood Cancer Discovery, September 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#7 of 226)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
12 news outlets
blogs
1 blog
twitter
54 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies
Published in
Blood Cancer Discovery, September 2023
DOI 10.1158/2643-3230.bcd-23-0049
Pubmed ID
Authors

Guido Lancman, Kian Parsa, Krzysztof Kotlarz, Lisa Avery, Alaina Lurie, Alex Lieberman-Cribbin, Hearn Jay Cho, Samir S. Parekh, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J. Sanchez, Santiago Thibaud, Sundar Jagannath, Ajai Chari

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 54 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 15%
Other 3 11%
Student > Doctoral Student 2 7%
Student > Postgraduate 2 7%
Student > Bachelor 1 4%
Other 2 7%
Unknown 13 48%
Readers by discipline Count As %
Medicine and Dentistry 7 26%
Agricultural and Biological Sciences 2 7%
Biochemistry, Genetics and Molecular Biology 1 4%
Unknown 17 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 120. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2024.
All research outputs
#378,604
of 26,746,748 outputs
Outputs from Blood Cancer Discovery
#7
of 226 outputs
Outputs of similar age
#7,036
of 369,223 outputs
Outputs of similar age from Blood Cancer Discovery
#1
of 15 outputs
Altmetric has tracked 26,746,748 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 226 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,223 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.